In this segment, Joyce O’Shaughnessy, MD; Debu Tripathy, MD; and Edith Perez, MD, review treatment options of human epidermal growth factor receptor (HER)-2-positive breast cancer.
- 9 жыл бұрын
Treatment of HER2-Positive Breast Cancer
- Рет қаралды 8,006
Пікірлер: 2